See more : Janover Inc. (JNVR) Income Statement Analysis – Financial Results
Complete financial analysis of Oneness Biotech Co., Ltd. (4743.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oneness Biotech Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Key Capital Corporation (KCPC) Income Statement Analysis – Financial Results
- Sensyne Health plc (SENS.L) Income Statement Analysis – Financial Results
- Netbay Public Company Limited (NETBAY-R.BK) Income Statement Analysis – Financial Results
- DiaSorin S.p.A. (DSRLF) Income Statement Analysis – Financial Results
- Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ) Income Statement Analysis – Financial Results
Oneness Biotech Co., Ltd. (4743.TWO)
About Oneness Biotech Co., Ltd.
Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, which is in pre-clinical stage for the treatment of allergic asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. The company was incorporated in 2008 and is headquartered in Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 86.78M | 1.07B | 65.77M | 41.61M | 13.48M | 18.86M | 2.59M | 5.70M | 7.84M | 5.48M | 4.61M | 8.60M | 3.72M | 59.09M | 1.63M |
| Cost of Revenue | 54.22M | 221.16M | 20.72M | 10.89M | 17.00M | 10.21M | 1.22M | 2.85M | 4.86M | 2.58M | 2.77M | 5.80M | 3.01M | 26.75M | 435.00K |
| Gross Profit | 32.56M | 844.39M | 45.04M | 30.72M | -3.53M | 8.65M | 1.37M | 2.85M | 2.99M | 2.90M | 1.84M | 2.80M | 703.00K | 32.34M | 1.20M |
| Gross Profit Ratio | 37.52% | 79.24% | 68.49% | 73.83% | -26.17% | 45.86% | 52.76% | 50.01% | 38.07% | 52.89% | 39.94% | 32.56% | 18.92% | 54.73% | 73.33% |
| Research & Development | 952.55M | 919.02M | 805.96M | 589.28M | 238.64M | 94.44M | 65.43M | 62.68M | 53.59M | 60.94M | 75.50M | 49.06M | 53.70M | 40.41M | 19.65M |
| General & Administrative | 121.95M | 120.35M | 94.31M | 107.10M | 68.81M | 45.51M | 69.87M | 50.59M | 40.06M | 52.37M | 36.29M | 30.17M | 20.96M | 13.93M | 8.85M |
| Selling & Marketing | 54.69M | 46.48M | 22.91M | 445.00K | 760.00K | 471.00K | 5.15M | 2.74M | 6.54M | 7.77M | 10.09M | 4.48M | 3.44M | 2.78M | 0.00 |
| SG&A | 176.64M | 166.83M | 117.22M | 107.55M | 69.57M | 45.98M | 75.03M | 53.33M | 46.60M | 60.14M | 46.38M | 34.64M | 24.41M | 16.71M | 8.85M |
| Other Expenses | 0.00 | 556.63M | 176.84M | 7.06M | 35.71M | -91.10M | 1.95M | 1.93M | 3.91M | 2.58M | 4.30M | 1.48M | 1.91M | 2.31M | 3.49M |
| Operating Expenses | 1.13B | 1.09B | 923.18M | 703.89M | 308.21M | 140.83M | 140.46M | 116.01M | 100.19M | 121.08M | 124.84M | 83.70M | 78.10M | 57.12M | 28.50M |
| Cost & Expenses | 1.18B | 1.31B | 943.90M | 714.78M | 325.21M | 151.04M | 141.68M | 118.86M | 105.05M | 123.66M | 127.60M | 89.50M | 81.11M | 83.87M | 28.94M |
| Interest Income | 282.70M | 51.02M | 29.93M | 12.81M | 6.68M | 0.00 | 0.00 | 5.44M | 7.74M | 2.05M | 2.45M | 3.22M | 4.18M | 4.80M | 3.84M |
| Interest Expense | 5.61M | 4.60M | 4.90M | 5.18M | 6.26M | 6.00K | 5.00K | 8.00K | 3.00K | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 422.40M | 494.15M | 196.86M | 192.13M | 65.82M | 11.41M | 5.00M | 4.27M | 7.01M | 6.42M | 5.00M | 7.36M | 4.36M | 3.14M | 1.22M |
| EBITDA | -674.23M | 860.35M | -474.51M | -52.15M | -259.56M | -211.88M | -150.68M | -4.45M | -86.29M | -111.76M | -117.34M | -76.16M | -73.04M | -21.63M | -26.09M |
| EBITDA Ratio | -776.91% | 89.24% | -294.56% | -125.34% | -1,883.94% | -1,237.22% | -5,824.55% | -170.87% | -1,100.52% | -2,039.75% | -2,127.42% | -2,077.79% | -1,834.21% | -65.30% | -2,885.65% |
| Operating Income | -1.10B | 456.22M | -391.06M | -244.76M | -320.00M | -132.19M | -139.09M | -113.15M | -97.21M | -118.18M | -123.00M | -80.90M | -77.40M | -24.77M | -27.31M |
| Operating Income Ratio | -1,263.64% | 42.82% | -594.64% | -588.30% | -2,374.80% | -701.03% | -5,376.61% | -1,984.10% | -1,239.74% | -2,156.93% | -2,668.58% | -941.03% | -2,083.42% | -41.92% | -1,674.19% |
| Total Other Income/Expenses | 278.12M | 695.35M | 482.18M | -5.18M | -14.53M | -112.76M | -16.83M | 98.90M | 3.90M | 340.49M | 429.28M | 54.67M | 90.82M | 23.30M | 32.67M |
| Income Before Tax | -818.50M | 451.63M | -395.96M | -249.94M | -326.26M | -244.94M | -155.92M | -14.26M | -93.31M | 222.31M | 306.28M | -26.32M | 13.42M | 1.61M | 5.36M |
| Income Before Tax Ratio | -943.16% | 42.38% | -602.09% | -600.75% | -2,421.23% | -1,299.01% | -6,027.17% | -249.99% | -1,189.99% | 4,057.49% | 6,645.26% | -306.14% | 361.32% | 2.72% | 328.88% |
| Income Tax Expense | 5.29M | 99.73M | 16.86M | 1.74M | 2.20M | -112.75M | -17.30M | 98.90M | -290.00K | 22.58M | 30.03M | 1.07M | -533.00K | 653.00K | -916.00K |
| Net Income | -1.31B | 359.98M | -412.82M | -251.68M | -328.46M | -235.44M | -155.45M | -14.26M | -93.02M | 199.73M | 276.25M | -27.39M | 13.96M | 953.00K | 6.28M |
| Net Income Ratio | -1,512.82% | 33.78% | -627.72% | -604.92% | -2,437.57% | -1,248.60% | -6,008.74% | -249.99% | -1,186.29% | 3,645.30% | 5,993.77% | -318.60% | 375.67% | 1.61% | 385.04% |
| EPS | -2.77 | 0.82 | -0.95 | -0.62 | -1.15 | -1.06 | -0.70 | -0.06 | -0.44 | 1.06 | 1.42 | -0.14 | 0.08 | 0.01 | 0.06 |
| EPS Diluted | -2.77 | 0.80 | -0.95 | -0.62 | -1.15 | -1.05 | -0.70 | -0.06 | -0.44 | 1.04 | 1.40 | -0.14 | 0.08 | 0.01 | 0.06 |
| Weighted Avg Shares Out | 473.40M | 441.49M | 433.70M | 406.02M | 285.75M | 222.72M | 222.33M | 221.63M | 212.84M | 189.33M | 194.32M | 194.11M | 180.36M | 175.17M | 96.91M |
| Weighted Avg Shares Out (Dil) | 473.40M | 447.94M | 433.70M | 406.02M | 285.75M | 223.65M | 223.26M | 222.56M | 213.73M | 191.93M | 196.99M | 194.63M | 180.38M | 175.17M | 97.00M |
Source: https://incomestatements.info
Category: Stock Reports